Yamanouchi and Fujisawa Strive for Global Mega-Player Status with Merger Agreement

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)

Published: 4 Apr-2004

DOI: 10.3833/pdr.v2004.i46.817     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Yamanouchi entered into an agreement to acquire Fujisawa, thus substantially expanding its product portfolio in prescription drug market...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details